Skip to content

Total Assets at other companies

Eli Lilly logo
Eli LillyLLY
$116.58B+30.4%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$40.87B+8.9%
AbbVie logo
AbbVieABBV
$136.46B+0.2%
Summit Therapeutics logo
Summit TherapeuticsSMMT
$647.86M+68.8%
Immunovant, Inc. logo
Immunovant, Inc.IMVT
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX

Other financials

Income statement

See full
Operating income-$82.8M-31.2%
Net income-$74.1M-33.9%
EPS (diluted)-$1.06-11.6%

Balance sheet

See full
Cash & equivalents$451.8M+323%
Total debt$8.0M-31.9%

Cash flow

See full
Operating cash flow-$55.6M-14.6%
CapEx$62.0K
Free cash flow-$62.8M+7.3%

Valuation

See full
Market cap$6.81B+189%
Enterprise value$6.37B+181%

Returns & leverage

See full
Current ratio32.6×+16.8×

Where this comes from

Reported directly by Apogee Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Apogee Therapeutics, Inc.'s total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Apogee Therapeutics, Inc.'s total assets?
Apogee Therapeutics, Inc. (APGE) reported total assets of $1.29B in Q1 2026.
How has Apogee Therapeutics, Inc.'s total assets changed year-over-year?
Apogee Therapeutics, Inc.'s total assets increased by 81.1% year-over-year, from $714.16M to $1.29B.
What is the long-term trend for Apogee Therapeutics, Inc.'s total assets?
Over 3 years (2022 to 2025), Apogee Therapeutics, Inc.'s total assets has grown at a 83.3% compound annual growth rate (CAGR), from $152.06M to $937.13M.
What does total assets mean?
The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.